It suggests that SP/NK-1R and neurogenic immunoreactivity are critical for the progression of airway hyperresponsiveness (AHR) (52), and NK-1R antagonists attenuated the AHR and plasma extravasation in animal models in vivo (51). Here, TACR1 is linked to airway hyperresponsiveness.